Biostimulant Industry Seeks Govt Support

1 Minute Read Listen to Article
Share:    

Aug 24, 2025 12:43

x
Biostimulant federation urges govt intervention to address trade barriers, regulatory delays. Support SMEs & boost market growth.
New Delhi, Aug 24 (PTI) The National Biostimulant Industry Federation (NBIF) on Sunday called for urgent government intervention to address regulatory bottlenecks in the domestic market and high tariffs abroad, which are hampering the sector's growth potential.

NBIF urged the Prime Minister Narendra Modi's office to coordinate reforms across key ministries to support an industry valued at Rs 40,000 crore and comprising over 5,000 small and medium enterprises.

Indian biostimulant exporters face tariffs of 15-28 per cent in key global markets, along with non-tariff barriers, including origin-specific efficacy trials and residue testing requirements, NBIF said in a statement.

The absence of mutual recognition agreements with major trading blocs, like the European Union and ASEAN, compounds these challenges.

Domestically, the industry is grappling with regulatory ambiguity and delays in product approvals under India's Fertiliser Control Order, with no dedicated testing protocols for natural substances like seaweed and humic acid.


"The industry doesn't need subsidies. What it needs is clear, science-driven, and industry-aligned regulation," NBIF President Rajit Choksi said.

India possesses significant natural advantages for biostimulant production, including a 7,500-kilometre coastline suitable for seaweed cultivation and lignite-rich regions for humic acid extraction.

Seaweed and humic-based products comprise over 70 per cent of the global USD 6.2 billion biostimulant market.

However, global companies are increasingly capturing India's domestic market, while local manufacturers struggle with regulatory clearances, according to NBIF Secretary General Sahil Malik.

The federation has proposed a series of policy reforms, including declaring biostimulants a strategic sector, establishing a national tariff strategy task force, and creating centralised testing facilities.

With appropriate reforms, India could expand its biostimulant market from Rs 4,000 crore to Rs 15,000 crore by 2030 while creating employment for over 1,00,000 agricultural workers and biotechnology professionals, NBIF said.
Share:    

TODAY'S MOST TRADED COMPANIES

  • Company Name
  • Price
  • Volume

See More >

Moneywiz Live!

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback